Domek-Łopacińska K, Strosznajder J B
Department of Cellular Signaling, Medical Research Center, Polish Academy of Sciences, Warsaw, Poland.
J Physiol Pharmacol. 2005 Mar;56 Suppl 2:15-34.
Cyclic GMP (cGMP) is synthesized by guanylyl cyclase (GC) in response to nitric oxide (NO) and carbon monoxide (CO) or natiuretic peptides (NPs); atrial, brain and C-type (ANP, BNP and CNP). cGMP is degraded by several cGMP-specific phosphodiesterases (PDEs). Guanylate cyclases (GC) are differentiated into: membrane-bound/particulate (pGC) and cytosolic/soluble (sGC). In recent years evidence has accumulated that NO is the main activator of sGC and NO/cGMP plays important role in glutaminergic, cholinergic and dopaminergic signaling pathways. cGMP in the nervous system is involved in long term potentiation and depression (LTP, LTD) suggesting its participation in learning and memory mechanism. cGMP regulates calcium homeostasis and phototransduction. Its level is regulated by PDEs and their specific inhibitors protect cGMP level in cells and are very important from clinical point of view.
环磷酸鸟苷(cGMP)由鸟苷酸环化酶(GC)响应一氧化氮(NO)、一氧化碳(CO)或利钠肽(NP)而合成;心房利钠肽、脑利钠肽和C型利钠肽(ANP、BNP和CNP)。cGMP由几种cGMP特异性磷酸二酯酶(PDE)降解。鸟苷酸环化酶(GC)可分为:膜结合/颗粒型(pGC)和胞质/可溶性型(sGC)。近年来,越来越多的证据表明,NO是sGC的主要激活剂,NO/cGMP在谷氨酸能、胆碱能和多巴胺能信号通路中起重要作用。神经系统中的cGMP参与长时程增强和抑制(LTP、LTD),表明其参与学习和记忆机制。cGMP调节钙稳态和光转导。其水平受PDE调节,它们的特异性抑制剂可保护细胞中的cGMP水平,从临床角度来看非常重要。